Elucidating the precise pharmacological system of action (MOA) of naturally transpiring compounds could be demanding. Whilst Tarselli et al. (60) produced the initial de novo synthetic pathway to conolidine and showcased this naturally taking place compound successfully suppresses responses to both chemically induced and inflammation-derived pain,